Controlled Substances Classification Table
Hospital Monitoring & Compliance Guide
Inventory Accuracy = (Physical Count / Expected Balance) × 100% ≥ 99.8%
| Category | Drug Examples | Schedule | Storage Requirements | Inventory Checklist | Documentation Requirements | Disposal Protocol |
|---|---|---|---|---|---|---|
| Opioid Analgesics | Morphine, Fentanyl, Oxycodone, Hydromorphone, Codeine | II | Double-locked cabinet; separate safe; temperature controlled; biometric access preferred | Daily physical count; reconcile with administration records; verify expiration dates; witness signature | Patient name, dose, time, prescribing physician, witness signature, lot number, patient ID verification | Reverse distributor; dual witness; DEA Form 222 for returns; documented chain of custody |
| Stimulants | Amphetamine (Adderall), Methylphenidate (Ritalin), Dextroamphetamine, Lisdexamfetamine | II | Locked vault; limited access; alarm system; separate dispensing area; inventory log | Per-shift count; weekly physical inventory; reconcile with dispensing logs; track lot numbers | Prescriber DEA number, patient ID, quantity dispensed, pharmacist verification, indication for use | DEA-authorized destruction; dual witness documentation; certificate of destruction required |
| Sedative-Hypnotics | Pentobarbital, Secobarbital, Phenobarbital (high doses), Amobarbital | II | Secure vault; access log; biometric locks; cool, dry storage; limited personnel access | Daily physical count; reconcile with MAR; verify seals; check temperature logs | Administration time, patient response, waste documentation (partial doses), two-nurse verification | Witnessed destruction; DEA Form 222; maintain destruction logs for 2+ years; video recording |
| Benzodiazepines | Diazepam, Lorazepam, Midazolam, Alprazolam, Clonazepam, Temazepam | IV | Locked cabinet; separate from Schedule II; temperature monitoring; restricted access | Weekly inventory; monthly audit; random counts; reconcile with prescription records | Prescription tracking, patient monitoring chart, sedation scoring, prescriber credentials | Standard pharmaceutical waste; documentation of quantity destroyed; dual witness |
| Ketamine | Ketamine HCl (all forms), Esketamine (Spravato) | III | Locked storage; restricted access; cool storage (2–8°C); separate anesthesia tracking | Bi-weekly inventory; usage tracking by department; reconciliation with surgical records | Anesthesia record, dose calculation, patient weight documentation, procedure type, recovery monitoring | Hazardous waste protocols; witnessed disposal; DEA notification for large quantities |
| Anabolic Steroids | Testosterone cypionate, Nandrolone, Oxandrolone, Stanozolol, Boldenone | III | Locked pharmacy storage; temperature monitored (15–30°C); separate from other controls | Monthly physical count; lot number tracking; expiration monitoring; usage trend analysis | Patient diagnosis justification, injection logs, prescribing physician credentials, informed consent | Return to manufacturer when possible; DEA Form 222 for returns; documentation of return reason |
| Buprenorphine | Suboxone (bup/naloxone), Subutex, Sublocade, Bunavail | III | Secure storage; separate dispensing area; DEA waiver verification required; patient registry | Daily dispensing logs; weekly inventory reconciliation; patient-specific tracking; film/tablet count | Patient counseling documentation, DEA X-waiver verification, induction protocols, treatment plan | Patient return program preferred; DEA-authorized disposal; documented witnessed destruction |
| Cough Preparations | Codeine cough syrup (≥90mg/dose), Hydrocodone cough syrup, Hydrocodone/acetaminophen | II / III | Locked cabinet; age verification protocols; quantity limits enforced; separate inventory | Per-shift counts; dispensing log reconciliation; verify prescription validity; track patient history | Patient ID verification, quantity limits, prescription validity check, pharmacist consultation note | Standard controlled substance disposal; documentation of destruction method; DEA Form 222 if applicable |
| Cannabis-Derived | Dronabinol (Marinol), Cannabidiol (Epidiolex), Cesamet (nabilone) | III / V | Secure, separate storage; state-specific requirements; seed-to-sale tracking where applicable | Daily inventory; state registry reconciliation; lot tracking; patient-specific dispensing records | State registry verification, patient certification, dosing protocols, adverse event monitoring, prescriber registration | State-specific destruction protocols; dual witness required; chain of custody documentation; DEA notification |
| Emergency Opioid Antagonists | Naloxone HCl (high-concentration 4mg/0.1mL, 2mg/2mL auto-injectors) | II / III | Emergency crash carts; temperature controlled (15–30°C); sealed containers; readily accessible | Daily cart checks; seal verification; expiration monitoring; replacement protocol after use; lot tracking | Administration timestamp, response documentation (ROSC), replacement protocols, incident reporting, waste reconciliation | Standard disposal for expired units; incident reporting if used; documentation of medical necessity; restocking verification |
Compliance Index = [(Accurate Records × Secure Storage × Proper Disposal) / Total Inventory Items] × 100
Risk Assessment Score = (Schedule Level × Quantity × Accessibility) / (Security Measures + Monitoring Frequency)
Important Compliance Note: This table provides a standardized operational framework for hospital pharmacy compliance. Specific protocols may vary based on local health authorities, institutional bylaws, regulatory scheduling (e.g., 21 CFR 1301–1308), and hospital accreditation requirements (JCI / CBAHI). Always consult designated compliance officers and current statutory guidelines for institution-specific protocols.
